Skip to main content
Sunday
December 01, 2024
Sign In
Subscribe
Home
Epaper
Economy
Aviation
Banking
Bazaar
Budget
Industry
NBR
RMG
Corporates
Stocks
Analysis
Videos
Podcast
World+Biz
Features
Book Review
Brands
Earth
Explorer
Food
Habitat
In Focus
Luxury
Mode
Panorama
Pursuit
Wheels
Subscribe
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Thoughts
Splash
Bangladesh
Supplement
Infograph
Archive
Gallery
Long Read
Interviews
Offbeat
Tech
Magazine
Climate Change
Health
Cartoons
বাংলা
SUNDAY,
DECEMBER 01, 2024
Sinopharm
Coronavirus chronicle
Some Omicron sub-variants escaping antibodies from Sinopharm shot
Coronavirus chronicle
Sinopharm protein-based booster stronger against Omicron than earlier shot -study
Middle East
UAE approves Sinopharm's protein-based vaccine
Covid-19 in Bangladesh
Local production of Sinopharm vaccine uncertain
Coronavirus chronicle
Sinopharm Covid-19 booster weaker against Omicron - study
Coronavirus chronicle
Canada to allow entry of travelers fully vaccinated with Sinopharm
Covid-19 in Bangladesh
Special vaccination campaign at community clinics from Saturday
Covid-19 in Bangladesh
50 lakh more doses of Sinopharm vaccine reach Dhaka
Covid-19 in Bangladesh
Over 54 lakh doses of Sinopharm vaccine reach Dhaka
Covid-19 in Bangladesh
20 lakh Sinopharm jabs arrived from China
Bangladesh
10 lakh Pfizer doses to arrive Wednesday
Coronavirus chronicle
Peru study finds Sinopharm Covid vaccine 50.4% effective against infections
Covid-19 in Bangladesh
10 lakh Sinopharm doses arrive from China
Show More
